According to foreign media reports, OpenAI is currently in late-stage negotiations for a massive funding round, with a valuation potentially reaching $150 billion. Sources have revealed that the company has requested investors to contribute at least $250 million. Previous reports indicated that OpenAI is close to securing a new funding round of $5 to $7 billion, led by Thrive Capital, which has pledged to invest $1 billion. Microsoft, NVIDIA, and Apple are in discussions regarding investment matters. One insider stated that these companies...

Biotechnology company Chai Discovery has received nearly $30 million in investment from Thrive Capital and OpenAI within six months of its founding. The company focuses on the application of biotechnology in drug development, developing innovative technologies that can predict biochemical molecular structures and reprogram molecular interactions, aiming to transform biology into 'engineering.' Chai Discovery's goal is to accelerate and optimize the drug development process by enhancing drug molecule design through technologies such as artificial intelligence and machine learning.

OpenAI, known for its innovative AI research and the influence of ChatGPT, is actively seeking a new round of funding with a target valuation of up to $100 billion, potentially making it one of the most valuable tech companies in the world. This funding round is expected to raise billions of dollars, with venture capital firm Thrive Capital and tech giant Microsoft showing strong interest, potentially investing $1 billion and over $13 billion, respectively. OpenAI's valuation has rapidly increased over the past few years, rising from $86 billion at the end of 2022.